07:00 , Aug 27, 2012 |  BC Week In Review  |  Company News

BioSyent deal

BioSyent's BioSyent Pharma Inc. subsidiary received exclusive Canadian rights to two undisclosed products from an undisclosed European partner. The company said its subsidiary's hospital products division will market the products following Canadian approval. BioSyent, which...
07:00 , May 14, 2012 |  BC Week In Review  |  Company News

BioSyent Inc., Pharmazeutische Fabrik Montavit Ges.m.b.H. sales and marketing update

BioSyent's BioSyent Pharma Inc. subsidiary launched sterile topical anesthetic Cathejell Jelly 2% in Canada for surface anesthesia and lubrication for various procedures, including male and female cystoscopies, catheterizations and other endourethral operations. BioSyent licensed Canadian...